News about Nature

First genetic marker for Multiple Sclerosis severity identified

This finding, published today in the journal Nature, opens the door to the development of new treatments to prevent long-term disability.

Clínic Barcelona

Research March 24 2021

A study in Nature concludes that immunotherapy is less efficacious in nonviral liver cancer

An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surviv1

Clínic Barcelona

Research November 4 2020

Researchers develop an epigenetic clock that predicts the future clinical behavior of cancer patients

Spanish investigators from the IDIBAPS-Hospital Clínic of Barcelona have led an international effort to develop an epigenetic clock that is able to t1

2 2

page1
page2 , current page.

News about Nature

First genetic marker for Multiple Sclerosis severity identified

A study in Nature concludes that immunotherapy is less efficacious in nonviral liver cancer

Researchers develop an epigenetic clock that predicts the future clinical behavior of cancer patients

navigation between pages below

Subscribe to the Newsletter of Clínic